George Herbert is a final year PhD student in Professor Stephen J. Archibald’s research group based in the Department of Biomedical Sciences at the University of Hull. He completed an integrated masters (MChem Chemistry with Molecular Medicine) in the group before progressing to his PhD in 2018. George’s research aims to develop and validate pulmonary drug delivery systems using fluorine-18 radiolabelling and positron emission tomography technology.
Based in the Positron Emission Tomography Research Centre (PETRC), the groups work focuses at the interface of chemistry and biology, developing new PET radiotracers for the diagnosis and treatment of disease (oncology, cardiovascular and infection). Research performed in the PETRC is progressed from concept to pre-clinical in vivo assessment. The new Medical Imaging Research Centre (MIRC) based at Castle Hull hospital is a custom-built facility that will allow leading-edge research to translated through clinical development.
Following the success of the work supported by the DDL Career Development Grant, George was able to secure a job as a Lead Radiochemist based at GE Healthcare. Starting in the autumn of 2021, he is in the final stages of completing his research and hopes to submit his thesis by December 2021.